FDA ADE reports for Fuzapladib

ade_fuzapladib_adverse_events

ade en 2026-07-22

Fuzapladib — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Fuzapladib is a active ingredient.

Total reports

Fuzapladib: 395

Reports by species (top entries)

Dog 369
Cat 3
Human 3

Top reported reactions (VEDDRA terms, top entries)

Death by euthanasia 86
Lack of efficacy - NOS 55
Death 39
Vomiting 38
Elevated total bilirubin 37
Abnormal ultrasound finding 36
Anorexia 36
Lethargy (see also Central nervous system depression in Neurological) 35
Diarrhoea 32
Elevated serum alkaline phosphatase (ALP) 32

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b15.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).

Sources

FDA ADE reports for Fuzapladib (active ingredient) — total reports, species & reaction breakdown

Source document: FDA FAERS / openFDA Animal & Veterinary Event Reports

US FDA Center for Veterinary Medicine (openFDA animal & veterinary event database)retrieved 2026-07-22

Verification file: pdf-raw/ade/ade_active_ingredients_2026-07-22_b15.json

Link points to the issuing authority's site; a direct document link is still being verified.

Machine access

AI agents: this page mirrors GET /api/v1/llm_context?topic=ade_fuzapladib_adverse_events (max 500 tokens, whitelisted). Rate limit 60 req/min for recognized AI crawlers.

Raw JSON ↗ llm.txt OpenAPI